| CTOR Stock | | | 1.08 0.01 0.92% |
Citius Oncology's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Citius Oncology's valuation are provided below:
Market Capitalization | Earnings Share |
There are over ninety available fundamental signals for Citius Oncology, which can be analyzed over time and compared to other ratios. Investors and active traders are advised to validate Citius Oncology's prevailing fundamental performance against the performance between
2010 and 2026 to make sure the trends are evolving in the right direction. As of 01/15/2026,
Market Cap is likely to drop to about 162.5
M. In addition to that,
Enterprise Value is likely to drop to about 162.4
MCheck out the analysis of
Citius Oncology Correlation against competitors.
To learn how to invest in Citius Stock, please use our
How to Invest in Citius Oncology guide.
Citius Oncology Balance Sheet | | |
|
Citius Oncology Income Statement | | |
|
Citius Oncology Cash Flow Statement | | |
|
Financial Ratios | | |
|
Citius Oncology Valuation Data | | |
|
Citius Oncology shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Citius Oncology investors may analyze each financial statement separately, they are all interrelated. The changes in Citius Oncology's assets and liabilities, for example, are also reflected in the revenues and expenses on on Citius Oncology's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our
fundamental analysis page.
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Citius Oncology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Citius Oncology will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Citius Oncology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Citius Oncology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Citius Oncology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Citius Oncology to buy it.
The correlation of Citius Oncology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Citius Oncology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Citius Oncology moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Citius Oncology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
When running Citius Oncology's price analysis, check to
measure Citius Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Citius Oncology is operating at the current time. Most of Citius Oncology's value examination focuses on studying past and present price action to
predict the probability of Citius Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Citius Oncology's price. Additionally, you may evaluate how the addition of Citius Oncology to your portfolios can decrease your overall portfolio volatility.